Abstract
Pain is the most prominent symptom interfering with quality of life in patients with rheumatic diseases. Therefore, pain reduction is rated as the most important outcome criteria in studies asking patients with rheumatoid arthritis for their preferences.1,2 However, since the introduction of biologics and the declaring of remission as the main target for those with rheumatic diseases by international societies (as is the case for treating rheumatoid arthritis), pain was somewhat out of focus. Only in recent years has pain been considered to be an integral part of studies of patients with rheumatic diseases and is investigated more frequently in clinical practice as an important patient-reported outcome measure.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
